Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
JAMA Neurology
|
July 11, 2017
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
Samuel Frank, David Stamler, Elise Kayson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits
Norbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Parkinsonism & Related Disorders
|
December 24, 2019
Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis
Ruth B Schneider, Joohi Jimenez-Shahed, Danielle S Abraham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 23, 2006
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families
Lianna Ishihara, Rachel A Gibson, Liling Warren, et al.
Neurology
|
August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson disease
Christopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
E Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
JAMA
|
July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial
, Samuel Frank, Claudia M Testa, et al.
JAMA
|
September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA Neurology
|
November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials
, Kevin Michael Biglan, Ira Shoulson, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
JAMA Neurology
|
July 11, 2017
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
Samuel Frank, David Stamler, Elise Kayson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits
Norbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Parkinsonism & Related Disorders
|
December 24, 2019
Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis
Ruth B Schneider, Joohi Jimenez-Shahed, Danielle S Abraham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 23, 2006
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families
Lianna Ishihara, Rachel A Gibson, Liling Warren, et al.
Neurology
|
August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson disease
Christopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
E Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
JAMA
|
July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial
, Samuel Frank, Claudia M Testa, et al.
JAMA
|
September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA Neurology
|
November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials
, Kevin Michael Biglan, Ira Shoulson, et al.
Page
of 7